Align Technology Inc ALGN
We take great care to ensure that the data presented and summarized in this overview for ALIGN TECHNOLOGY INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ALGN
View all-
Vanguard Group Inc Valley Forge, PA8.38MShares$2.27 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY7.66MShares$2.08 Billion0.06% of portfolio
-
State Street Corp Boston, MA3.05MShares$829 Million0.05% of portfolio
-
Jpmorgan Chase & CO New York, NY2.29MShares$621 Million0.07% of portfolio
-
Alliancebernstein L.P. New York, NY1.78MShares$484 Million0.21% of portfolio
-
Geode Capital Management, LLC Boston, MA1.72MShares$467 Million0.05% of portfolio
-
Sands Capital Management, LLC Arlington, VA1.36MShares$368 Million1.3% of portfolio
-
Capital World Investors Los Angeles, CA1.26MShares$341 Million0.07% of portfolio
-
Brown Advisory Inc1.23MShares$334 Million0.55% of portfolio
-
Polen Capital Polen Capital Management LLC | Boca Raton, Fl1.22MShares$330 Million0.92% of portfolio
Latest Institutional Activity in ALGN
Top Purchases
Top Sells
About ALGN
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Insider Transactions at ALGN
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 29
2024
|
Joseph Lacob |
SELL
Open market or private sale
|
Indirect |
15,000
-3.49%
|
$4,545,000
$303.77 P/Share
|
Feb 27
2024
|
Joseph Lacob |
SELL
Open market or private sale
|
Indirect |
10,000
-6.37%
|
$3,130,000
$313.01 P/Share
|
Feb 20
2024
|
Julie Ann Coletti EVP, CHIEF LEGAL & REGULATORY |
SELL
Payment of exercise price or tax liability
|
Direct |
1,269
-21.46%
|
$397,197
$313.53 P/Share
|
Feb 20
2024
|
Julie Ann Coletti EVP, CHIEF LEGAL & REGULATORY |
BUY
Grant, award, or other acquisition
|
Direct |
3,069
+34.16%
|
-
|
Feb 20
2024
|
Joseph M Hogan PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,674
-3.8%
|
$2,714,962
$313.53 P/Share
|
Feb 20
2024
|
Joseph M Hogan PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
19,574
+7.9%
|
-
|
Feb 20
2024
|
Emory Wright EVP, GLOBAL OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,755
-17.46%
|
$549,315
$313.53 P/Share
|
Feb 20
2024
|
Emory Wright EVP, GLOBAL OPERATIONS |
BUY
Exercise of conversion of derivative security
|
Direct |
3,533
+26.01%
|
-
|
Feb 20
2024
|
Stuart A Hockridge EVP GLOBAL HR |
SELL
Payment of exercise price or tax liability
|
Direct |
1,139
-10.53%
|
$356,507
$313.53 P/Share
|
Feb 20
2024
|
Stuart A Hockridge EVP GLOBAL HR |
BUY
Grant, award, or other acquisition
|
Direct |
2,765
+20.36%
|
-
|
Feb 20
2024
|
John Morici EVP & CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,835
-12.37%
|
$574,355
$313.53 P/Share
|
Feb 20
2024
|
John Morici EVP & CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
4,450
+23.08%
|
-
|
Feb 07
2024
|
Emory Wright EVP, GLOBAL OPERATIONS |
SELL
Open market or private sale
|
Indirect |
2,524
-26.27%
|
$724,388
$287.47 P/Share
|
Nov 09
2023
|
Joseph M Hogan PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
5,194
+2.43%
|
$997,248
$192.5 P/Share
|
Oct 31
2023
|
Joseph M Hogan PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
5,319
+2.55%
|
$999,972
$188.0 P/Share
|
Jul 20
2023
|
Julie Ann Coletti EVP, CHIEF LEGAL & REGULATORY |
SELL
Payment of exercise price or tax liability
|
Direct |
150
-5.18%
|
$49,500
$330.99 P/Share
|
Jul 20
2023
|
Julie Ann Coletti EVP, CHIEF LEGAL & REGULATORY |
BUY
Exercise of conversion of derivative security
|
Direct |
320
+9.94%
|
-
|
May 30
2023
|
Kevin J Dallas Director |
BUY
Open market or private purchase
|
Direct |
7,000
+36.37%
|
$1,995,000
$285.26 P/Share
|
May 30
2023
|
George J Morrow Director |
SELL
Bona fide gift
|
Indirect |
10,000
-75.34%
|
-
|
May 17
2023
|
Greg J Santora Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,114
+8.5%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 10.3K shares |
---|---|
Exercise of conversion of derivative security | 32.7K shares |
Open market or private purchase | 17.5K shares |
Payment of exercise price or tax liability | 14.8K shares |
---|---|
Exercise of conversion of derivative security | 1.11K shares |
Bona fide gift | 10K shares |
Open market or private sale | 27.5K shares |